India Set To Select Business Leader of The Year Award 2012 at Pharmaceutical Leadership Awards 2012

India Set To Select Business Leader of The Year Award 2012 at Pharmaceutical Leadership Awards 2012

Dr Mukesh Batra, Dilip Sanghavi, Dr Krishna Ella & R.C.Juneja are in the race to the prestigious Pharmaleaders’s 5^th Annual Business Leadership Awards 2012

Mumbai, Maharashtra,Friday, 31^st August 2012 :  As Asia’s Biggest Leadership Event In Healthcare & Biotechnology Annual Event Is Coming Closer, The Battle For The Business Leader Of The Year Award 2012 goes deeper & intense as the nation is set to select the winner from the four finalists who made it to the Nomination at 5^th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2012 ( www.asiapharmaleaders.com )in a nationwide voting currently underway. Organised by Asia’s Most Analytical Healthcare Bi-Monthly Pharmaleaders ( www.pharmaleaders.co.in ), The Award Title has four big players in the Indian Pharmaceutical & Healthcare Industry with a successful track record of establishing their respective businesses both in india & overseas with a huge branding.

In the race to the prestigious title are, Dilip Sanghavi, MD, Sun Pharmaceutical IndustriesLtd , Dr Krishna Ella, CMD, Bharat Biotech International Ltd Dr.  Mukesh Batra, Founder Chairman, Dr Batra’s.& R. C. Juneja, Managing Director, Mankind Pharma Ltd. Sun Pharma Chief Sanghavi runs india’s biggest pharmaceutical Empire called Sun Pharma while Dr Ella is a reputed veteran in  Botech Research with a scientific mindset. Padmashree Dr Mukesh Batra is India’s pioneer Homeopath Doctor who revolutionized india’s thinking towards the homeopathy & Mankind Pharma Chief Juneja is a Brand Icon who quickly catapulted to the top 10 by some aggressive marketing. Commenting on the competation, Satya Brahma, Editor-In-Chief of Breakfast News TV ( www.breaklfastnews.tv ) said “ It will be phenomenally difficult for the respondents who are asked to name only one out four big names. However, this competition is  bound to be competitive as the names have tremendous brand value”. Harvard trained, eminent Indian American iconic Heart Surgeon & Research Scientist Dr Mukesh Hariawala  who will deliver the keynote lecture on receipt of this year’s prestigious " India's Most Admired Surgeon  award said “ This category will have much to say, the way Indian healthcare landscape is progressing, while the voters will have their respective views on their personal choices to cast their vote, at the end of the day, they will have to choose one & this will be huge recognition said Dr Hariawala.    

Pharmaceutical Leadership  Awards have been presented since last one decade at a sold-out gala to over 500 industry executives and leading academic scientists from around the world. Each Award or Nomination are being screened by the Board Members of Pharma Leaders Group consisting of 12 Member Team & than further approved by Network 7 Media Group consisting of eminent members of the Healthcare Community. After through screening, the names of four Nominees emerge out & are thrown out to public by E-mail Voting, Than SMS Voting followed by the final verdict of the Jury Members. The Awards demonstrate how companies can, through their core business activities, help achieve excellence in innovations. The 2012 Award Nominations has been given explicitly to companies delivering inclusive business models which are sustainable, commercially-viable business initiatives that expand access for low-income people to goods and services, or improve their livelihoods by engagement in value chains as direct employees, suppliers or distributors, while also generating sales and profit growth. By bringing together examples of innovative, effective business practices, 5th Annual Pharmaceutical Leadership Awards will also provide leading businesses and entrepreneurs with a valuable platform for networking and sharing experiences, and promote best practices. This will encourage other businesses and governments to replicate and scale initiatives. An international judging panel made up of representatives of the organizing partners as well as non-governmental organizations, universities, business entities, and international institutions will determine this year’s winners. A knowledge-exchange workshop focussed on inclusive business will take place prior to the awards ceremony.

In 2011, the Awards received an unprecedented 172 nominations, representing a variety of business and commercial endeavors undertaken by business associations, non-governmental organizations and individual companies from more than 9 countries sample size of 5 Lakh 56 thousand & 674 voters spread across 21  states & 4 industry verticals via online, sms & physical interviews . “Past Award winners have shown how companies can help boost sustainable growth and development,” said Satya Brahma. “They can be a tremendous source of innovative and sustainable solutions, which help transform people’s lives for the better." These Awards will highlight the critical role of the private sector in stimulating sustainable economic growth and development.” A detailed Analysis of career graph/History or notable achievement is looked at to get the final four names. Such as ,Financial management, Decision making roles and business impact,Business ethics,Managing rapid growth,Innovation,Adapting to change,Strategic partnerships,          Leadership roles,Marketing strategies,Corporate philanthropy/contributions to society.

The Winner will be announced on Friday, 21^st September 2012 at Hotel Hilton Mumbai International Airport at the gala Award Night which will also have a International Summit on theme Brand India, Beyond Generics : Leading with Resilience: Coming Back from Challenge and Heading Towards Super-power Status.

Pfizer’s Kewal Handa, GSK’s’s Dr Hasit Joshipura, Abbott’s Sudarshan Jain, Ranbaxy’s Arun Arun Sawhney, Emcure’s Satish Mehta, Sanofi Aventis’s Dr. Shailesh Ayyangar, & Microlab’s Ashok jain, to receive the coveted title at 5th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2012

Pharma Professionals Of The Decade At 5^th Annual Pharmaceutical Leadership Awards To Recognize Shining Stars Of Indian Healthcare Industry

Pfizer’s Kewal Handa, GSK’s’s Dr Hasit Joshipura, Abbott’s Sudarshan Jain, Ranbaxy’s Arun Arun Sawhney, Emcure’s Satish Mehta, Sanofi Aventis’s Dr. Shailesh Ayyangar, & Microlab’s Ashok jain, to receive the coveted title at 5^th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2012

Maharashtra, Mumbai, Friday, 17th August 2012: Indian Pharmaceutical & Biotech Industry over the years has evolved out in the global map as the leading destination & manufacturing hub for sourcing pharmaceutical API’s & Formulations. Indian Pharmaceutical Sector has the distinction of being one of the most preferred location for export of pharmaceutical products at affordable prices. Indian pharmaceutical industry is poised to grow at the rate of 18 per cent by the year 2016-17, the Parliament was informed today. "According to the Report of the Working Group on Drugs and Pharmaceuticals Industry for XII Five Year Plan, the projected rate of growth for Indian Pharmaceutical industry is envisaged as 18 per cent by 2016-17," Minister of State for Chemicals and Fertilizers Srikant Kumar Jena said in a written reply to Indian Parliament. The projected rate of growth of the industry in domestic market has been envisaged as 21 per cent and the projected growth rate in the international market has been envisaged as 16 per cent, he added. "The estimated value of business of the Pharmaceuticals Industry in 2008 was Rs 80,300 crore which reached to Rs 1,04,209 crore in March 2010," Jena said.

Undoubtedly, the robust growth of Indian Pharmaceutical Industry in India as well as in abroad would not have been possible without the visionary leadership & farsighted outlook of the mentors, professionals of the Industry. “There are many who made it possible for translating the ideas into action, the dreams into reality & local into global said Satya Brahma, Chairman, Organising Committee of 5^th Annual Pharmaceutical Leadership Summit & Awards 2012 ( www.asiapharmaleaders.com ), however, we decided to nominate the contemporary leaders with a strong visionary professionals who transformed Indian Healthcare Industry in many ways both to the Industry in general & their respective Company in particular  as “Pharma Professionals of The Decade 2012”.

Those who will don the mantle & will be felicitated at the glittering Award Ceremony on 21^st September in Mumbai at the Pharmaleaders’s ( www.pharmaleaders.co.in ) in association with Pharmexcil. India Brand Equity Foundation (IBEF) under the support from Ministry of Industry & Commerce, Government of India. are Pfizer’s Kewal Handa, GSK’s’s Dr Hasit Joshipura, Abbott’s Sudarshan Jain, Ranbaxy’s Arun Arun Sawhney, Emcure’s Satish Mehta, Sanofi Aventis’s Dr. Shailesh Ayyangar & Microlab’s Ashok jain” added Satya Brahma in a News Release. Kewal Handa who will retire from the Board Members of Pfizer India & Wyeth will receive the coveted Title Transformational Pharma Leader of the Decade for his outstanding contribution to the Indian Healthcare Industry & changing the business landscape of Pfizer India’s presence in india & making it as the leading company in healthcare business.

5^th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2012 are running on a theme Brand India, Beyond Generics – Growth, Development & Diversifications.

His Excellency, Governor of Maharashtra, Shri Kateekal Sankaranarayanan in the presence of distinguished, dignitaries will give away the coveted Awards to the shingning stars of Indian Healthcare Sector such as Pfizer’s Kewal Handa, GSK’s’s Dr Hasit Joshipura, Abbott’s Sudarshan Jain, Ranbaxy’s Arun Arun Sawhney, Emcure’s Satish Mehta, Sanofi Aventis’s Dr. Shailesh Ayyangar, & Microlab’s Ashok jain at the glittering Award Night in a suburban Hotel in Mumbai on  Friday, 21^st September 2012.

Aanjaneya Lifecare Eyes European Market, To Forge Collaborate Research with a German Pharma Major

Aanjaneya Lifecare Eyes European Market, To Forge Collaborate Research with a German Pharma Major

Middle East, Gulf & African Continents top on Agenda post Aanjaneya’s Robust Fiscal Growth Q1 Net  at 68 pc

‎Maharashtra, Mumbai, Monday, 13^th August 2012. In a sequel to Mumbai based Mid Cap Pharma Major Aanjaneya Lifecare’s grand acquisition in the beginning of this year in Feb which  was a first takeover by any Pharma Company. Aanjaneya Lifecare acquired Apex Drugs and Intermediates (ADI), a Hyderabad-based integrated active pharmaceutical ingredient (API) and intermediate company, for Rs.250 crore, including debt of Rs.185 crore and equity dilution of Rs.65 crore.

Sources close to pharmaledaers reveal that Aanjaneya Lifecare is close on partnering with a German Pharma major for collaborate Research, Crams & Co-Marketing Rights to sell the product range in the Middle East, Gulf & African Continents. In a Press Note to BSE, Aanjaneya Lifecare which announced its Q1 results informed the regulator that, The Board Members have approved the plans to set up offices in overseas markets such as Uganda, Tanzania, Dubai and Singapore. Aanjaneya had raised Rs 117 crore from its successful  IPO & has indicated that the funds will be used for Research, Crams & global expansion. The repeated attempts to reach aanjaneya Lifecare Spokesperson by Pharmaleaders yielded no results & sms sent to Dr Kannan Vishwanath, Vice-Chairman & MD was unanswered.

Pharmaleaders has learnt from its sources that Aanjaneya Lifecare, after successfully acquiring Apex Drugs which will will reduce the company's dependence on third parties for pricing and supply to a large extent & will open up doors for lifestyle segment was looking for a Research Partner to make its presence in NDDS, NCE & Crams in a big way, the proposesd collaboration will enhance the capabilities in a big way says Satya Brahma, Editor-In-Chief of Pharmaleaders, “Aanjaneya is on a road to its entering into the big league as Aanjaneya has a strong presence in API and formulation business and has bulk drug manufacturing facility at Mahad and a finished dosage forms unit near Pune. It is one of the largest contract manufacturers of codeine-based cough syrups in India and exclusively makes Codorex brand of Zydus Cadilla and Codilite tablets among others”. It may be noted here that the Shares of Aanjaneya Lifecare today closed at Rs 616.20 on BSE.

Aanjaneya Lifecare has been selected for Nomination for prestigious title “BSE Award for Best Return to Investors” organized by Pharmaleaders in association with Pharmexcil , Ministry of Commerce & Industry along with leading trade bodies at 5^th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2012 in Mumbai on 21^st September.

Biocon Chief Dr. Kiran Majumdar Shaw & NMC Chief Dr B.R.Shetty Declared Global Indian Of The Year

Biocon Chief  Dr. Kiran Majumdar Shaw & NMC Chief Dr B.R.Shetty Declared Global Indian Of The Year

5^th Annual Pharmaceutical Leadership Awards 2012 will crown the iconic global leaders in Mumbai. Global Indian of the Year are  the highest title of recognition from Pharmaleaders.

Thursday, 9^th August 2012, Mumbai, Maharashtra:  When going gets tough, tough gets going, there are times when we have seen great iconic global figures have had their challenging days in an era of protectionist policy & license raj, yet unfazed & optimist of their dreams – to cross geographic boundaries, think global , embrace innovation in work & make it big yet remain simple in thinking, these are the signs of global icons & yes two such iconic personalities who have compelled the world to take note of their startling success are Dr Kiran Mazumdar Shaw of Biocon & Dr B R Shetty of NMC Healthcare. 5^th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2012 ( www.asiapharmaleaders.com )  organised by Asia’s leading bi-monthly healthcare magazine Pharmaleaders (www.pharmaleaders.co.in ) will salute these two global icons in the commercial capital of India, Mumbai on 21^st September 2012 with the presence of who’s & who’s of healthcare industry, pharma academia, policy makers, brand icons & corporate biggies. Dr Kiran Mazumdar Shaw & Dr B .R. Shetty have been declared by the distinguished juries of the Pharmaleaders as “ Global Indian of the Year 2012” .

Announcing the names of Dr Kiran Shaw & Dr B R Shetty, Satya Brahma, Editor-In-Chief of Pharmaleaders Group said “ The Board Members of Pharmaleaders had no other names when it came to globe-throttling mission & making it big in global map purely on the strength of their self-belief, confidence & exuberance, Dr Kiran Shaw & Dr B R Shetty are the shining stars of the global healthcare Industry while one conquered in Biotechnology, the other experimented with quite a lot of different segments in healthcare, yet remained adamant on their objective, to become a global player”, added satya in a release to media. “It is indeed heartening to note that both of them cherished a dream quite contrary to other business leaders, their indomitable thinking, positive energy & meteoric rise to the global space has much to tell us that they have defied all odds & worked in a very hostile climate & earned the goodwill of becoming rarest of rare in business innovations said Satya. We are excited to give these two global icons.

 “It is a great honor for me to be nominated as the Global India of the Year 2012. I am deeply humbled and grateful to you for recognizing my achievements & I look forward to attending the Summit and Awards Ceremony” said Dr Shetty to Satya Brahma.

Dr. B.R.Shetty is the Founder, Managing Director & CEO of NMC Healthcare is a partner with Centurion Investments which is under the patronage of His Highness Sheikh Mansour bin Zayed Al Nahayan. Dr.B.R.Shetty was born in an agricultural family in Kaup, India. A graduate in Pharmacology, Dr.B.R.Shetty’s meteoric rise to the top is an awe inspiring testimony to what hardwork, passion and dedication can achieve. Over three decades after its inception, under Dr.B.R.Shetty’s dynamic leadership, NMC has flowered into a multi-activity conglomerate encompassing a diverse spectrum of businesses like Oil Field Supply and Oil Related Business, Healthcare, Financial Services & Money Remittances, Hospitality etc. Dr.Shetty is today considered a pioneer in healthcare and has been credited for being the first to offer a comprehensive range of healthcare services which cover the entire gamut of medical diagnosis and treatment under a single umbrella. Today, the NMC Healthcare family consists of six healthcare facilities in the UAE Dr. Shetty has acquired a hospital in Alexandria, Egypt which operates under the name of Alexandria New Medical Centre. Dr. B. R. Shetty’s clear vision and focus, indefatigable spirit and unflagging enthusiasm, has made him an active partner in the progress of the UAE. Dr. Shetty is committed to the cause of well being and health of its people, and his zeal is as strong as ever to spearhead this mission of change.

It takes originality and a strong will for a woman to first study brewing, and then to turn to a nascent industry when hurdles in the brewery business prove insurmountable. Kiran Mazumdar-Shaw, Chairman and Managing Director of Biocon, India's first biotechnology company. Biocon, today a billion-dollar company and Asia's largest biopharma concern, started in the garage of Mazumdar-Shaw's rented home in Bangalore, with seed capital of Rs10,000 (around Rs4 lakh today). When she set up what is now one of the top 20 biotechnology companies in the world, banks wanted her father. Her vision for the company has evolved from the goal of improving India's scientific record to the dream of "a made-in-India novel drug". When she talks about Biocon's plans to take insulins global and move from cancer care to cancer cure, her enthusiasm seems almost childlike.

5^th Annual Pharmaceutical Leadership Summit 2012 will also debate on crucial topics of the healthcare industry on Brand India theme by the veterans of the industry. The much awaited Event will be represented by many corporate tycoons & overseas healthcare experts.